NCT02329366View on ClinicalTrials.gov

Development of a Cellular Biomarker for the Diagnosis and Treatment of Diabetic Foot Ulcers

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 1, 2017

Study Completion Date

December 1, 2020

Conditions
Diabetic Foot UlcerType 2 Diabetes
Interventions
OTHER

Specimen Collection

. In this study, diabetic patients undergoing DFU debridement under the standard of care will be asked for their permission to collect the debrided tissue for use in scientific research.

Trial Locations (1)

11501

Winthrop University Hospital, Mineola

All Listed Sponsors
lead

Winthrop University Hospital

OTHER

NCT02329366 - Development of a Cellular Biomarker for the Diagnosis and Treatment of Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter